Literature DB >> 34894035

Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the community.

Su-Chen Lim1, Deirdre A Collins1, Korakrit Imwattana2,3, Daniel R Knight2,4, Sicilia Perumalsamy2, Natasza M R Hain-Saunders1,4, Papanin Putsathit1, David Speers2,5, Thomas V Riley1,2,4,5.   

Abstract

AIMS: To investigate if Clostridium (Clostridioides) difficile infection (CDI), traditionally thought of as hospital-acquired, can be genomically linked to hospital or community environmental sources, and to define possible importation routes from the community to the hospital. METHODS AND
RESULTS: In 2019, C. difficile was isolated from 89/300 (29.7%) floor and 96/300 (32.0%) shoe sole samples at a tertiary hospital in Western Australia. Non-toxigenic C. difficile ribotype (RT) 010 predominated among floor (96.6%) and shoe sole (73.2%) isolates, while toxigenic RT 014/020 was most prevalent among contemporaneous clinical cases (33.0%) at the hospital. Whole-genome sequencing and high-resolution core genome single nucleotide polymorphism (cgSNP) analysis on C. difficile strains from hospital and community sources showed no clinical C. difficile RT 014/020 strains were genetically related, and evidence of frequent long-distance, multi-directional spread between humans, animals and the environment. In addition, cgSNP analysis of environmental RT 010 strains suggested transportation of C. difficile via shoe soles.
CONCLUSIONS: While C. difficile RT 014/020 appears to spread via routes outside the healthcare system, RT 010 displayed a pattern of possible importation from the community into the hospital. SIGNIFICANCE AND IMPACT OF STUDY: These findings suggest developing community-based infection prevention and control strategies could significantly lower rates of CDI in the hospital setting.
© 2021 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990CDIzzm321990; One Health; environmental; epidemiology; phylogenetics; transmission; zoonosis

Mesh:

Year:  2021        PMID: 34894035     DOI: 10.1111/jam.15408

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   4.059


  3 in total

Review 1.  Capturing the environment of the Clostridioides difficile infection cycle.

Authors:  Matthew K Schnizlein; Vincent B Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

2.  Whole-Genome Sequencing of Pathogenic Bacteria-New Insights into Antibiotic Resistance Spreading.

Authors:  Andrey Shelenkov
Journal:  Microorganisms       Date:  2021-12-19

Review 3.  Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.

Authors:  Deirdre A Collins; Thomas V Riley
Journal:  Lett Appl Microbiol       Date:  2022-02-11       Impact factor: 2.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.